Parallax Volatility Advisers
TXMD icon

Parallax Volatility Advisers’s TherapeuticsMD TXMD Stock Holding History

Parallax Volatility Advisers’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,000
Closed -$487K – 3312
2018
Q1 		$487K Buy
+2,000
New +$561K ﹤0.01% 1129

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Parallax Volatility Advisers's TXMD Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 52 shares — an estimated $1K sold.

Parallax Volatility Advisers first reported a position in TXMD in Q4 2017 and held it in 7 quarters. The position peaked at $184K in Q1 2018. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

  • Parallax Volatility Advisers reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 52 TherapeuticsMD shares in Q1 2022, an estimated $1K.
  • Parallax Volatility Advisers first reported a position in TherapeuticsMD in Q4 2017 and held it in 7 quarters.
  • Parallax Volatility Advisers's TherapeuticsMD position peaked at $184K in Q1 2018.
  • 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.